Carbohydrate (CHO) intake during exercise could decrease the subjective perceived exertion and promote recovery; however, the effects of intra-training CHO ingestion remain uncertain in CrossFit® (CF) sessions. Therefore, the aim of this randomized, triple-blind, placebo-controlled crossover trial was to investigate the effect of acute CHO intake during a CF session on the delayed onset muscle soreness (DOMS), the perceived exertion (RPE), performance, recovery, and metabolic markers (capillary lactate and glucose) in CF athletes. Twenty-three male athletes trained in CF ingested CHO (60g of maltodextrin + fructose) or a placebo (PLA) during a CF session. DOMS was assessed 24 and 48h after the CF session. The Counter Movement Jump (CMJ) test and the Deep Squat test at 70% of the athlete's body weight (AST70) were performed before, immediately after, and 24h after the session. Perceived exertion, Feeling Scale (FS), Gastrointestinal Distress Score (GDS), heart rate, capillary lactate, and glucose were assessed across the session. CHO supplementation did not improve DOMS (all P ≥ 0.127), CMJ, or AST70 parameters (all P ≥ 0.053) compared to PLA. There were no differences between CHO and PLA in RPE, FS, GDS, heart rate (all P ≥ 0.088), performance (e.g., nº of repetitions; all P ≥ 0.556), or lactate levels (P = 0.810). However, glucose levels increased from the back squat to the WOD and remained stable after the AMRAP (P < 0.001). In conclusion, acute CHO intake during a CF session did not improve DOMS, perceived exertion, performance, recovery, or metabolic markers in CF athletes. TRN: NCT06440343. Date: 2024-05-10.
Read full abstract